Study shows third course of Lemtrada improves MS patient’s relapse rate and disability
A study released at #ACTRIMS2018 has revealed that patients who experienced relapses after two courses of Lemtrada (alemtuzumab) showed improvement in relapse rate and disability progression after a third course of the drug…Read more - http://www.ms-uk.org/study-shows-third- ... disability
Third course of Lemtrada improves MS patient’s relapse rate
Third course of Lemtrada improves MS patient’s relapse rate
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post